All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  Â
Sicriptin 1.25mg Tablet
Prescription Required
Salt Composition : Bromocriptine
Manufacturer : SERUM INSTITUTE OF INDIA
Origin of Medicine : India
10 Tablet(s) In A Strip
Get financial assistance directly from pharma companies and cover your cost of medicines or get free medicines for the eligible patient with patient assistance programs (PAP). We provide proper guidance to patients enrolled in the patient assistance program.
Introduction to Sicriptin 1.25mg Tablet
Sicriptin 1.25mg tablet contains an active component as Bromocriptine. It is a medication used to treat various medical conditions. It belongs to a class of drugs known as dopamine agonists, activating certain dopamine receptors in the brain. Dopamine is a neurotransmitter, and its regulation is essential for several physiological functions. It is primarily used to treat conditions characterized by elevated levels of the hormone prolactin in the blood (hyperprolactinemia). High prolactin levels can cause various issues, including infertility, irregular menstrual periods, and milk production in non-pregnant women.
Additionally, it is used as an adjunct therapy for Parkinson's disease, improving motor symptoms by activating dopamine receptors. Sicriptin 1.25mg tablet can also be part of the treatment for acromegaly, a condition resulting from excess growth hormone production. In emergencies, this medication can manage neuroleptic malignant syndrome, a rare and potentially life-threatening condition associated with certain antipsychotic medications. Although not a primary diabetes medication, It has been used off-label to improve glycemic control in patients with type 2 diabetes potentially.
Individuals with known hypersensitivity or allergy to Sicriptin 1.25mg tablet or any of its components should not take this medication. This medication can cause changes in blood pressure, and it is contraindicated in individuals with uncontrolled hypertension (high blood pressure). This medication is contraindicated in individuals with postpartum hypertension or a history of toxemia of pregnancy. Patients with a history of cardiovascular disorders, including angina, myocardial infarction, or peripheral vascular disease, should use Sicriptin 1.25mg tablet with caution due to potential effects on blood pressure. This medication can affect the central nervous system and may exacerbate certain psychiatric conditions. Caution is needed when prescribing this medication to individuals with a history of psychiatric disorders.
Uses of Sicriptin 1.25mg Tablet
Sicriptin 1.25mg tablet is used to treat the following:
- Hyperprolactinemia
- Parkinson's disease
- Acromegaly
- Neuroleptic malignant syndrome (NMS)
- Type 2 diabetes (off-label use)
Therapeutic Effects of Sicriptin 1.25mg Tablet
Sicriptin 1.25mg tablet exerts its therapeutic effect as a dopamine agonist, activating dopamine receptors in the brain. This results in regulating dopamine levels and leads to various beneficial outcomes. This medication lowers prolactin levels in hyperprolactinemia, alleviating associated symptoms like irregular menstrual periods and infertility. For Parkinson's disease, it improves motor symptoms by compensating for dopamine deficiency.Â
In acromegaly, it reduces growth hormone levels, mitigating abnormal tissue growth. It can also manage neuroleptic malignant syndrome emergencies. While occasionally used off-label, it may help improve glycemic control in patients with type 2 diabetes. These diverse therapeutic effects make this medication valuable in treating various medical conditions related to dopamine imbalance.
Interaction of Sicriptin 1.25mg Tablet with other drugs
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Sicriptin 1.25mg tablet, reducing effectiveness by causing undesirable side effects.
More Information about Sicriptin 1.25mg Tablet
- Store at room temperature, between 20°C to 25°C (68°F to 77°F).
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep away from children and pets.
How to consume Sicriptin 1.25mg Tablet
Sicriptin 1.25mg tablet should be taken exactly as prescribed by a healthcare professional. It is available in various forms, such as tablets or capsules. The dosage and frequency depend on the medical condition being treated. This medication can be taken with or without food, and patients should not adjust the dosage or stop taking it without medical guidance. Adherence to the prescribed schedule is crucial, and any potential side effects should be promptly reported to the healthcare provider.
Safety Advices for Sicriptin 1.25mg Tablet
 Â
Pregnancy
 Â
Pregnant women or those planning to become pregnant should discuss all potential risks and benefits of using Sicriptin 1.25mg tablet with their healthcare provider. The decision to use this medication during pregnancy should be made collectively, considering the specific medical condition and individual circumstances.
 Â
Breast Feeding
 ÂSicriptin 1.25mg tablet's safety during breastfeeding is a significant consideration, and its use should be carefully evaluated and monitored by a healthcare professional.
 Â
Lungs
  If you have a lung-related medical condition, it is essential to consult with a qualified healthcare professional who can properly evaluate your specific condition and medical history.
 Â
Liver
  If you have liver-related medical conditions, such as liver disease or liver dysfunction, it is crucial to inform your healthcare provider about your condition before starting Sicriptin 1.25mg tablet or any other medication.
 Â
Alcohol
 Â
Combining Sicriptin 1.25mg tablet with alcohol is generally not recommended. Alcohol can interact with this medication and may enhance its central nervous system depressant effects, leading to increased drowsiness, dizziness, and impaired coordination. This combination can be dangerous and may lead to serious side effects.
 Â
Driving
  The use of Sicriptin 1.25mg tablet may cause certain side effects, such as dizziness, drowsiness, or lightheadedness, that can potentially impair cognitive and motor skills. As a result, it may not be safe to drive or operate heavy machinery while taking it, especially when starting the medication or when the dosage is adjusted.
Side Effects of Sicriptin 1.25mg Tablet
Sicriptin 1.25mg tablet cause some side effects like all medications, although not everyone will experience them.Â
Serious:
- Hallucinations or confusion
- Mental/mood changes
- Difficulty breathing
- Uncontrolled movements or twitching (dyskinesias)
- Chest pain or rapid heart rate
- Fainting or loss of consciousness
- Yellowing of the skin or eyes (jaundice)
- Signs of liver problems (e.g., dark urine, pale stools)
- Signs of an allergic reaction (e.g., rash, itching, swelling, severe dizziness)
Common:
- Nausea
- Vomiting
- Headache
- Dizziness
- Fatigue or drowsiness
- Lightheadedness
- Abdominal discomfort or pain
- Dry mouth
- Constipation
- Changes in blood pressure (both low and high blood pressure)
- Swelling in the legs or ankles
Word of Advice
Patients with cardiovascular disorders, such as a history of heart disease or uncontrolled hypertension, require close monitoring due to potential blood pressure changes. Patients with a history of psychiatric disorders or impulse control issues should be closely monitored for any exacerbation of symptoms. Caution is advised in patients with liver dysfunction, as dosage adjustments may be necessary. The medication should not be used during the early postpartum period or in women with certain pregnancy-related conditions. Breastfeeding should generally be avoided while using Sicriptin 1.25mg tablet. If patients experience allergic reactions or any concerning symptoms, immediate medical attention should be sought. Your health is invaluable, and taking a proactive and informed approach to your well-being is crucial for a happy and fulfilling life.
FAQs
Q 1. Can Sicriptin 1.25mg tablet treat menstrual migraines?
Sicriptin 1.25mg tablet has been studied for its potential to reduce the frequency and severity of menstrual migraines, although it is not a primary treatment for this condition. However, its use should be determined by a healthcare professional based on individual needs and medical history.
Q 2. Can I safely use Sicriptin 1.25mg tablet if I have a history of cardiovascular issues?
Patients with a history of cardiovascular disorders, such as heart disease or uncontrolled hypertension, need to exercise caution while using Sicriptin 1.25mg tablet due to its potential to cause changes in blood pressure. It is crucial to inform your healthcare provider about your medical history before starting the medication, as they can closely monitor your condition and make necessary adjustments to ensure your safety. Avoid self-medicating and always follow your healthcare provider's advice for the safe use of it.
Q 3. Is weight gain a common side effect of Sicriptin 1.25mg tablet?
Weight gain is not a common side effect of Sicriptin 1.25mg tablet. It is more often associated with weight loss due to its effect on regulating appetite and metabolism. However, individual responses to medications can vary, and some patients may experience weight changes while taking it.
Q 4. Is Sicriptin 1.25mg tablet available as a nasal spray or injection?
While Sicriptin 1.25mg tablet is primarily available in oral tablet or capsule forms, in some cases, healthcare providers may prescribe it as a nasal spray or injection for specific medical conditions. The form of administration will depend on the patient's needs and treatment goals.
Q 5. Can Sicriptin 1.25mg tablet be used for weight loss?
Sicriptin 1.25mg tablet has been investigated for its potential in weight management due to its effect on regulating appetite and metabolism. However, its use for weight loss is not approved, and more research is needed to determine its safety and efficacy in this context.
Q 6. Can Sicriptin 1.25mg tablet be used for managing prolactinomas in men?
While hyperprolactinemia and prolactinomas are more common in women, Sicriptin 1.25mg tablet can also be used to manage prolactinomas in men. As with any medical treatment, individualized care and supervision are essential.
Fact Box of Sicriptin 1.25mg Tablet
Molecule name: Bromocriptine | Therapeutic class: Antiparkinsonian agent and Prolactin inhibitor |
Pharmacological class: Dopamine agonists
| Indications:Â 1. Hyperprolactinemia 2. Parkinson's disease 3. Acromegaly 4. Neuroleptic malignant syndrome (NMS) |
References
- Mylan Pharma; Electronic Medicines Compendium; [Revised: 11 Mar 2022] [Accesses: 20/July/2023]; https://www.medicines.org.uk/emc/files/pil.11939.pdf
- VeroScience, LLCÂ Ltd; FDA (Food and Drug Safety Administration); [Revised on: September 2010] [Accessed: 20/July/2023]; https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020866s006s007lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
